Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 14:10 PM 2012  
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for KUN and BNLB ...

Asset Comparison and Correlation

    
       
Investment horizon: 
30 Days (Login to change)
       
 
    
 China Shenghuo Pharmaceutical   and   Bond Laboratories Inc.
Check Correlation Matrix  
Daily Returns (%)
BNLB  KUN  
Timeline
Considering 30-days investment horizon, China Shenghuo Pharmaceutical Holdings Inc. is expected to generate 0.95 times more return on investment than Bond. However, China Shenghuo Pharmaceutical Holdings Inc. is 1.05 times less risky than Bond. It trades about 0.05 of its potential returns per unit of risk. Bond Laboratories Inc. is currently generating about -0.07 per unit of risk. If you would invest 16.00 in China Shenghuo Pharmaceutical Holdings Inc. on April 26, 2012 and sell it today you would lose (2.00) from holding China Shenghuo Pharmaceutical Holdings Inc. or give up 12.5% of portfolio value over 30 days.

Diversification

Significant diversification
Overlapping area represents amount of risk that can be diversified away by holding China Shenghuo Pharmaceutical and Bond Laboratories Inc. in the same portfolio (assuming nothing else is changed)

Correlation Coefficient

0.02
 Parameters
Time Period1 Month [change]
DirectionPositive BNLB.OB Moved Up vs KUN
StrengthInsignificant
Accuracy45.45%
ValuesDaily Returns
    
Follow Correlation between KUN and BNLB with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Correlation between KUN and BNLB to your reader
 
Get social with Correlation between KUN and BNLB
 Share Correlation between KUN and BNLB 
Share Share Correlation between KUN and BNLB
    
    
 
       
Predicted Return Density
Expected Daily Returns   
BNLB  KUN  

China Shenghuo Pharmaceutical Holdings I

 
    
    
China
Performance
2
Out Of
100
Over 30
Days
98% of all equities and portfolios perform better than China Shenghuo Pharmaceutical Holdings Inc.. Compared with the overall equity markets, risk-adjusted returns on investments in China Shenghuo Pharmaceutical Holdings Inc. are ranked lower than 2 (%) of all global equities and portfolios over the last 30 days.
    
    
Federal National Mortgage Association vs. China Shenghuo Pharmaceutical Holdings Inc.
KDDI CORP vs. China Shenghuo Pharmaceutical Holdings Inc.
SK Innovation vs. China Shenghuo Pharmaceutical Holdings Inc.
A.P. M vs. China Shenghuo Pharmaceutical Holdings Inc.
Citigroup Inc. vs. China Shenghuo Pharmaceutical Holdings Inc.
AngloGold Ashanti Ltd. vs. China Shenghuo Pharmaceutical Holdings Inc.
  

Bond Laboratories Inc.

 
    
    
Bond
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Bond Laboratories Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Perrigo vs. Bond Laboratories Inc.
Herbalife Ltd. vs. Bond Laboratories Inc.
Auxilium Pharmaceuticals Inc. vs. Bond Laboratories Inc.
Prestige Brands Holdings Inc. vs. Bond Laboratories Inc.
USANA Health Sciences Inc. vs. Bond Laboratories Inc.
Lifevantage Corporation vs. Bond Laboratories Inc.
       


 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting